Investors

Board of Directors

Chris Rigg, CEO

A Chartered accountant, who qualified with PwC, Chris Rigg was appointed as CEO in October 2016. He was appointed to the Board as CFO in March 2016 and has been Acting CEO since 1 August 2016.

Prior to joining the Group, Chris has held a number of senior financial positions including being a Corporate Finance Director at Deloitte, Group Corporate Finance Director at eaga plc and head of large corporate lending at Barclays Bank in the North East of England.

Chris also brings strategic, commercial and operational experience having been Managing Director of eaga plc's solar division, where led the £300 million fund raise to support its development, and as CEO of Northern Recruitment Group Limited.

Gerard Murray, CFO

Having been finance director for a number of publicly quoted companies, Gerard brings a wealth of experience to the Group. He qualified as a Chartered Accountant with Arthur Andersen and spent over ten years serving as CFO and then CEO of Reg Vardy plc before joining Northgate plc as group finance director for a five year period. Both of these quoted companies experienced considerable growth during the periods that he served on their respective boards. Gerard also has sector experience from a period as group finance director of Immunodiagnostic Systems Holdings PLC.

More recently he led the sale of Benfield Motor Group, a family owned motor retailer for £87.5 million to Lookers plc in September 2015 before joining Ardent Hire Solutions Limited, a private equity backed plant hire business, where he was the CFO since April 2016.

Non-executives

Ian Johnson, Non-Executive Chairman

Ian Johnson is an experienced director in the healthcare and life science sector. He was founder and CEO of Biotrace International plc until its sale to 3M in 2006 and is currently Executive Chairman of Bioquell PLC and non-executive Chairman of Cyprotex plc. Ian has also served on the boards of various public and private companies in strategic consultancy and business development capacities including: Celsis International, Evans Analytical Group, MyCelx Technologies Corporation and AOI Medical Inc. Ian is a chartered biologist and a member of the Royal Society of Biology and the Institute of Directors.

Dr John Brown, Senior Independent Non-Executive Director

Dr John Brown is an experienced non-executive director who has extensive experience in the life sciences and healthcare sectors. He is Chairman of Kyowa Kirin International and the Cell and Gene Therapy Catapult and a Director of Electrical Geodesics Inc. His board experience includes his roles as Chairman of Touch Bionics Ltd, BTG plc, and Axis-Shield plc, and as a Director of Vectura Group plc, Cambridge Antibody plc and Acambis plc.

Christopher Mills, Non-Executive Director

Christopher Mills is an experienced non-executive Director. He founded Harwood Capital Management Ltd in 2011, a successor from its former parent company J O Hambro Capital Management Ltd, which he co-founded in 1993. He is Chief Executive of North Atlantic Smaller Companies Investment Trust plc, a Director and Investment Manager of Oryx International Growth Fund Ltd and Chief Investment Officer of Harwood Capital LLP. He is also a non-executive Director of several AIM-listed companies. Christopher was a Director of Invesco MIM, where he was head of North American investments and venture capital and of Samuel Montagu International.

 

Page last updated: 23 January 2017

Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
Biodose Intelligent Medication Management
Biodose Services